Showing 3581-3590 of 19355 results for "".
Quantifying CKD-aP: Tools for Better Care
https://reachmd.com/programs/cme/quantifying-ckd-ap-tools-for-better-care/36295/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Case Application: Unlocking Relapsed/Refractory Myeloma With CELMoDs
https://reachmd.com/programs/cme/case-application-unlocking-relapsedrefractory-myeloma-with-celmods/36574/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityBreaking Barriers in AML: Risk Stratification, Molecular Profiling, and Novel Menin-Directed Treatment Options
https://reachmd.com/programs/cme/breaking-barriers-in-aml-risk-stratification-molecular-profiling-and-novel-menin-directed-treatment-options/33175/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Potassium Binders in Practice: Clinical Trial Evidence
https://reachmd.com/programs/cme/tbd/37672/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Stratifying Risk to Guide Therapy in R/R AML
https://reachmd.com/programs/cme/stratifying-risk-to-guide-therapy-in-rr-aml/36177/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
https://reachmd.com/programs/medical-industry-feature/tau-neurodegeneration-alzheimers-biomarkers/37875/For the latest insights on tau and neurodegeneration biomarkers in Alzheimer’s disease (AD), tune in to this recorded presentation featuring Doctor Michelle Mielke and Professor Henrik Zetterberg. Together, they delve into the role of tau in AD, exploring the ‘tau cascade’, the current use of tau aExpert Perspectives on Nonsteroidal MRAs and Cardiorenal Protection
https://reachmd.com/programs/cme/expert-perspectives-on-nonsteroidal-mras-and-cardiorenal-protection/32990/Hear experts discuss the potential clinical implications of data in heart failure presented at the 2Potassium Binders: Safety Comes First!
https://reachmd.com/programs/cme/tbd/37673/Learn from a multidisciplinary faculty panel how to Improve outcomes for patients with CKD and HFrEF using optimal RAASi and MRAs while managing hyperkalemia with potassium binders.Turmeric Tonic as a Treatment in Scalp Psoriasis
https://reachmd.com/programs/practical-dermatology-focus-psoriasis/turmeric-tonic-as-a-treatment-in-scalp-psoriasis/24460/Peter Lio, MD, leads this analysis of a study on the effectiveness of a topical turmeric preparation for mild-to-moderate scalp psoriasis. While the trial results indicated a reduction in Psoriasis Area & Severity Index (PASI) scores and improved quality of life for participants using the turmerNew and Emerging PAH Therapies and Approaches: A Mixture of Hope and Complexity
https://reachmd.com/programs/cme/new-and-emerging-pah-therapies-and-approaches-a-mixture-of-hope-and-complexity/36095/There are new and emerging therapies for PAH. Hear our experts discuss treatment approaches and why making the right diagnosis is key for selecting and individualizing therapy.